Propeller Health
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$1.9m | Debt | ||
$5.0m | Series A | ||
$14.5m | Series B | ||
$21.5m | Series C | ||
$20.0m | Series D | ||
* | $225m Valuation: $225m | Acquisition | |
Total Funding | $61.0m |
Related Content
Recent News about Propeller Health
EditPropeller Health operates in the digital health sector, focusing on asthma and Chronic Obstructive Pulmonary Disease (COPD) management. The company serves patients, healthcare providers, and payers by offering a mobile health platform that integrates with sensors attached to inhalers. These sensors collect data on medication usage and environmental factors, which is then analyzed to provide personalized insights and treatment adjustments. Propeller Health's business model revolves around selling its platform and sensors to healthcare providers and payers, who then distribute them to patients. The company generates revenue through subscription fees and data analytics services. By leveraging technology, Propeller Health aims to improve patient outcomes, reduce healthcare costs, and enhance the quality of life for individuals with respiratory conditions.
Keywords: digital health, asthma management, COPD, mobile platform, sensors, personalized treatment, healthcare providers, data analytics, FDA-cleared, patient outcomes.